title: Alirocumab (Praluent) for Treatment of Hyperlipidemia.
authors.affiliation: University of Virginia Health System, Charlottesville, VA, USA.
authors.forename: Patrick L
authors.initials: PL
authors.lastname: Turner
authors.affiliation: University of Virginia Health System, Charlottesville, VA, USA.
authors.forename: Kathleen A
authors.initials: KA
authors.lastname: Barry
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D050197:Atherosclerosis / Q000150:complications / Q000188:drug therapy*; D003221:Confusion / Q000139:chemically induced; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D008569:Memory Disorders / Q000139:chemically induced
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000924:Anticholesteremic Agents; C571059:alirocumab